메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
연세대학교 의과대학 Yonsei Medical Journal Yonsei Medical Journal 제59권 제5호
발행연도
2018.1
수록면
567 - 579 (13page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
With advancements in diagnostic techniques, including molecular and clinical imaging, that directly target cancer cells, oligometastaticprostate cancer (PCa) is being diagnosed in patients who were, in the past, considered to have localized disease. Withaccumulating evidence, there has been a paradigm shift in considering aggressive treatments targeted at both the primary tumorand metastatic lesions in an aim to avoid and delay the need for palliative treatments and, ultimately, to achieve survival benefits. However, many questions still remain unanswered regarding the understanding of oligometastatic PCa, from its definition to optimaltreatment strategies for each individual. Limited retrospective studies have suggested that interventions, including localand/or metastasis-directed therapy using surgery and radiation therapy (RT), can improve survival outcomes with minimal riskof adverse effects. Such treatments have been shown to decrease the risks of subsequent palliative interventions and to delay thestart of androgen-deprivation therapy. Nevertheless, available data are insufficient to draw a reliable conclusion regarding theireffect on quality of life measures and overall survival. This comprehensive review overviews data from contemporary literaturethat have investigated treatments, including surgery and RT, for patients with oligometastatic PCa, namely pelvic lymph nodepositive disease and limited distant metastases, and summarizes ongoing trials that are evaluating the feasibility of aggressivemultimodal treatments.

목차

등록된 정보가 없습니다.

참고문헌 (97)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0